Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JBIO is expected to report earnings to fall 93.78% to -41 cents per share on May 19
Q1'25
Est.
$-0.41
Q4'24
Missed
by $6.21
The last earnings report on March 26 showed earnings per share of -661 cents, missing the estimate of -40 cents. With 521.58K shares outstanding, the current market capitalization sits at 656.45M.